Workflow
Tips
icon
Search documents
X @The Wall Street Journal
President Trump promised “no tax on tips,” but for some workers, the details in the megabill say something else.🔗: https://t.co/Ie2uTG28fc https://t.co/cifc53u9W2 ...
X @The Wall Street Journal
President Trump promised “no tax on tips,” but for some workers, the details in the megabill say something else https://t.co/xbgI96WS3i ...
Trump signs no tax on tips or overtime into with 'One, Big, Beautiful Bill'
NBC News· 2025-07-05 16:56
We will have no tax on tips, no tax on overtime. That was a campaign promise of President Trump's. Now he's signing it into law as part of his so-called one big beautiful bill.As this takes effect, the impact on the economy and individuals will likely be mixed. Tipped workers make up just 2 and 12% of the US workforce, and as many as 40% of those tipped workers already don't make enough money to have to pay federal income tax on any of their earnings. Still, about 12% of hourly workers clock some overtime e ...
X @Forbes
Forbes· 2025-07-04 00:20
10 Essential Travel Tips For First Time Visitors To Japan https://t.co/ERxup7gmqx ...
X @Forbes
Forbes· 2025-07-03 11:32
10 Essential Travel Tips For First Time Visitors To Japan https://t.co/0LrJsqTPKv ...
Deputy Treasury Secretary Faulkender: Still looking to bring tax bill to Senate floor on Thursday
CNBC Television· 2025-06-24 12:55
President Trump and his team making one final push to get the president's tax bill across the finish line by next week. Michael Falcon there is uh the deputy treasury secretary and uh Mr. . Secretary it's good to see you from watching from where we are.It just seems like there's you know so many we're going to have Ran Paul on for example there's so many different constituencies you know single person constituencies on both of we just had Michael on as well. Are you confident that when push comes to shove t ...
X @Forbes
Forbes· 2025-06-11 00:40
5 Survival Tips For Working Moms With Kids Home This Summer https://t.co/Xej7nDS1Fe https://t.co/Xej7nDS1Fe ...
永安期货贵金属早报-20250605
Yong An Qi Huo· 2025-06-05 03:30
贵 金 属 比 价 贵金属早报 研究中心宏观团队 2025/06/05 价 格 表 现 品种 伦敦金 伦敦银 伦敦铂 伦敦钯 WTI原油 LME铜 最新 3364.60 34.35 1058.00 1005.00 62.85 9634.50 变化 29.85 0.10 -13.00 41.00 -0.56 89.50 | 交 易 数 据 | | --- | | 日期 | COMEX白银 | 上期所白银 | 黄金ETF持仓 | 白银ETF持仓 | 上金所白银 | 上金所黄金 | 上金所白银 | | --- | --- | --- | --- | --- | --- | --- | --- | | | 库存 | 库存 | | | 库存 | 递延费支付方向 | 递延费支付方向 | | 最新 | - | 1087.21 | 935.65 | 14552.37 | 1396.61 | 1 | 2 | | 变化 | - | 18.36 | 0.00 | 135.72 | 0.00 | -1.00 | 1.00 | 升 贴 水 、 库 存 、 E T F 持 仓 变 化 以上图表数据来源:彭博、永安源点资讯、万得 免责声明 ...
Insights Live: Real Estate And Your Financial Plan | Fidelity Investments
Fidelity Investments· 2025-06-03 07:00
The new year is a great time to revisit your financial plan and make sure all aspects of your financial house are in order. Join the Insights from Fidelity Wealth Management℠ team as we address this broad subject. Specific topics we'll cover include: - Choosing short, medium, and long-term goal and strategies for achieving them - Creating plans for unexpected events like market volatility, job loss, and inheritance - Ensuring your investment strategy and asset allocation are aligned with your goals - Tax ti ...
Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting
Prnewswire· 2025-05-27 13:00
Group 1 - Vanda Pharmaceuticals Inc. will participate in the ASCP Annual Meeting from May 27 to May 30, 2025, presenting pharmacokinetic results of Milsaperidone and Iloperidone [1] - The presentation will include a poster titled "Pharmacokinetic Results of Single-Dose and Multiple-Dose Bioequivalence Studies of Milsaperidone and Iloperidone Immediate-Release Oral Tablets" [1] Group 2 - Bysanti™ is a new atypical antipsychotic drug that, if approved, could be available for sale in the US in 2026 [2] - Bysanti™ is expected to interact with various neurotransmitter receptors, including alpha-adrenergic, serotonin, and dopamine receptors [2] - Patent exclusivity for Bysanti™ could extend into the 2040s [2] Group 3 - Vanda Pharmaceuticals Inc. is focused on developing and commercializing innovative therapies to meet high unmet medical needs [3]